Literature DB >> 14516825

Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.

Christina Canakis1, Charalampos Livir-Rallatos, Zafirakis Panayiotis, Gerasimos Livir-Rallatos, Efstratios Persidis, Mandi D Conway, Gholam A Peyman.   

Abstract

PURPOSE: To describe the anatomical and functional outcome of verteporfin ocular photodynamic therapy (PDT) in serous retinal detachment caused by the diffuse retinal pigment epitheliopathy form of chronic idiopathic central serous chorioretinopathy.
DESIGN: Interventional case report.
METHOD: A 48-year-old Caucasian man with unilateral exudative retinal detachment from diffuse retinal pigment epitheliopathy and visual acuity of 20/40 was managed with verteporfin PDT applied sequentially in three separate spots targeting all retinal pigment epithelium leaks identified with intravenous fluorescein angiography (IVFA). Outcome measures included visual acuity, biomicroscopic appearance, and leakage on IVFA.Clinical practice. Subretinal fluid resolved within 2 weeks; visual acuity returned to 20/20 with no recurrence at 6 months of follow-up. There was no leakage on IVFA posttreatment and no obvious toxicity. To our knowledge, this is the first report of PDT causing resolution of macular detachment in diffuse retinal pigment epitheliopathy. Its long-term results with regard to the prognosis of the disease and the recurrence rate remain to be evaluated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516825     DOI: 10.1016/s0002-9394(03)00397-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study.

Authors:  Yildirim Bayezit Sakalar; Ugur Keklikci; Kaan Unlu; Mehmet Fuat Alakus; Ismail Hamdi Kara
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

2.  Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.

Authors:  Andrea Russo; Raffaele Turano; Francesco Morescalchi; Elena Gambicorti; Anna Cancarini; Sarah Duse; Ciro Costagliola; Francesco Semeraro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-10       Impact factor: 3.117

Review 3.  Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.

Authors:  H Q Lu; E Q Wang; T Zhang; Y X Chen
Journal:  Eye (Lond)       Date:  2015-10-30       Impact factor: 3.775

4.  Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.

Authors:  T Y Y Lai; W-M Chan; H Li; R Y K Lai; D T L Liu; D S C Lam
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

5.  Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  Sergio Copete; Jose M Ruiz-Moreno; Carlos Cava; Javier A Montero
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-06       Impact factor: 3.117

Review 6.  Photodynamic therapy in macular diseases of asian populations: when East meets West.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Yasuo Tano; David T L Liu; Kenneth K W Li; Dennis S C Lam
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

7.  Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series.

Authors:  Ahmed S Al-Hinai; Mohammed S Al-Abri
Journal:  Oman J Ophthalmol       Date:  2011-05

8.  Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.

Authors:  Gholam A Peyman; Michael Tsipursky; Nariman Nassiri; Mandi Conway
Journal:  J Ophthalmic Vis Res       Date:  2011-07

9.  Photodynamic therapy and central serous chorioretinopathy.

Authors:  Lina Siaudvytyte; Vaida Diliene; Goda Miniauskiene; Vilma Jurate Balciuniene
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012

10.  Intravitreous injection of conbercept for bullous retinal detachment: A case report.

Authors:  Xiao-Li Xiang; Yi-Hong Cao; Ting-Wang Jiang; Zheng-Ru Huang
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.